These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20716873)

  • 21. Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
    Kalinina T; Bockhorn M; Kaifi JT; Thieltges S; Güngör C; Effenberger KE; Strelow A; Reichelt U; Sauter G; Pantel K; Izbicki JR; Yekebas EF
    Int J Cancer; 2010 Oct; 127(8):1931-40. PubMed ID: 20104520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients.
    Cunningham MP; Essapen S; Thomas H; Green M; Lovell DP; Topham C; Marks C; Modjtahedi H
    Int J Oncol; 2006 Feb; 28(2):329-35. PubMed ID: 16391786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic breast cancer.
    Köstler WJ; Hudelist G; Rabitsch W; Czerwenka K; Müller R; Singer CF; Zielinski CC
    J Cancer Res Clin Oncol; 2006 Jan; 132(1):9-18. PubMed ID: 16184380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations between Her2 oncoprotein, VEGF expression, MVD and clinicopathological parameters in gastric cancer.
    Bădescu A; Georgescu CV; Vere CC; Crăiţoiu S; Grigore D
    Rom J Morphol Embryol; 2012; 53(4):997-1005. PubMed ID: 23303024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
    Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G
    Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies.
    Heskamp S; Boerman OC; Molkenboer-Kuenen JD; Oyen WJ; van der Graaf WT; van Laarhoven HW
    Int J Cancer; 2013 Jul; 133(2):307-14. PubMed ID: 23335047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
    Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
    J Clin Pathol; 2018 May; 71(5):451-462. PubMed ID: 29138285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression and significance of IGF-1R and VEGF in gastric carcinoma].
    Liu WD; Yu R; Zhou GR
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jun; 25(6):529-30. PubMed ID: 19500509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.
    Yoshioka T; Shien K; Namba K; Torigoe H; Sato H; Tomida S; Yamamoto H; Asano H; Soh J; Tsukuda K; Nagasaka T; Fujiwara T; Toyooka S
    Cancer Sci; 2018 Apr; 109(4):1166-1176. PubMed ID: 29465762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer.
    Arias-Pulido H; Chaher N; Gong Y; Qualls C; Vargas J; Royce M
    BMC Cancer; 2012 Jul; 12():298. PubMed ID: 22813402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor-1 receptor expression in thymic malignancies.
    Girard N; Teruya-Feldstein J; Payabyab EC; Riely GJ; Rusch VW; Kris MG; Zakowski MF
    J Thorac Oncol; 2010 Sep; 5(9):1439-46. PubMed ID: 20736806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer.
    Park JS; Kim HS; Bae YS; Cheong JH; Rha SY; Noh SH; Kim H
    Jpn J Clin Oncol; 2016 Jun; 46(6):507-16. PubMed ID: 27008850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer.
    Sclafani F; Kim TY; Cunningham D; Kim TW; Tabernero J; Schmoll HJ; Roh JK; Kim SY; Park YS; Guren TK; Hawkes E; Clarke SJ; Ferry D; Frödin JE; Ayers M; Nebozhyn M; Peckitt C; Loboda A; Mauro DJ; Watkins DJ
    J Natl Cancer Inst; 2015 Dec; 107(12):djv258. PubMed ID: 26405092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy.
    Ha SY; Lee J; Jang J; Hong JY; Do IG; Park SH; Park JO; Choi MG; Sohn TS; Bae JM; Kim S; Kim M; Kim S; Park CK; Kang WK; Kim KM
    Int J Cancer; 2015 Apr; 136(7):1629-35. PubMed ID: 25157953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastric cancer: the role of insulin-like growth factor 2 (IGF 2) and its receptors (IGF 1R and M6-P/IGF 2R).
    Pavelić K; Kolak T; Kapitanović S; Radosević S; Spaventi S; Kruslin B; Pavelić J
    J Pathol; 2003 Nov; 201(3):430-8. PubMed ID: 14595755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis.
    Shimizu C; Hasegawa T; Tani Y; Takahashi F; Takeuchi M; Watanabe T; Ando M; Katsumata N; Fujiwara Y
    Hum Pathol; 2004 Dec; 35(12):1537-42. PubMed ID: 15619214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor receptor-1 (IGF-1R) expression in normal breast, proliferative breast lesions, and breast carcinoma.
    Bhargava R; Beriwal S; McManus K; Dabbs DJ
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):218-25. PubMed ID: 21217522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of expression of insulin-like growth factor-1 receptor in gastric adenocarcinomas and normal gastric tissues.
    Topalak Ö; Uğur Kantar F; Ulukuş Ç; Küpelioğlu A
    Turk J Gastroenterol; 2014 Apr; 25(2):141-6. PubMed ID: 25003672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45.
    Li H; Adachi Y; Yamamoto H; Min Y; Ohashi H; Ii M; Arimura Y; Endo T; Lee CT; Carbone DP; Imai K; Shinomura Y
    Cancer; 2011 Jul; 117(14):3135-47. PubMed ID: 21264842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic significance of growth factors and growth factor receptors in gastric adenocarcinoma.
    Kim JY; Jeon TJ; Bae BN; Kwon JE; Kim HJ; Park K; Shin E
    APMIS; 2013 Feb; 121(2):95-104. PubMed ID: 23030255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.